Kestra Private Wealth Services LLC cut its stake in CVS Health Co. (NYSE:CVS – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,422 shares of the pharmacy operator’s stock after selling 399 shares during the period. Kestra Private Wealth Services LLC’s holdings in CVS Health were worth $1,635,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the third quarter valued at about $25,000. Livelsberger Financial Advisory bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health during the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health in the third quarter valued at $32,000. Finally, Ridgewood Investments LLC lifted its position in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.
CVS Health Price Performance
Shares of CVS stock opened at $63.23 on Thursday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The firm has a market cap of $79.57 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. The stock has a 50-day moving average price of $50.61 and a 200 day moving average price of $55.92.
CVS Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.21%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
Analysts Set New Price Targets
Several research analysts recently issued reports on the stock. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday. Royal Bank of Canada cut their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. TD Cowen upped their price target on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a report on Tuesday, December 3rd. Finally, Wolfe Research boosted their target price on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research note on Tuesday. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average target price of $67.78.
Read Our Latest Research Report on CVS Health
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Stock Analyst Ratings and Canadian Analyst Ratings
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.